Glenn Pierce, Director at Voyager Therapeutics, Inc. (VYGR), sold 19,024 shares at $6.70 ($127K) on 2022-07-14, disclosed to the SEC on 2022-07-18.
Open-market sale of $127k VYGR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.70 | 9,512 | $64K | 50.0% |
| 2 | $6.70 | 9,512 | $64K | 50.0% |
| Total | $6.70 avg | 19,024 | $127K | 100% |